Company Filing History:
Years Active: 2023
Title: The Innovations of Stefan Grudén
Introduction
Stefan Grudén is a notable inventor based in Stockholm, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative dosage forms. His work focuses on improving the administration of medications for various lung diseases.
Latest Patents
Stefan Grudén holds a patent for a "Dry powder composition for peroral administration." This pharmaceutical dosage form is designed for peroral administration to the gastrointestinal tract. The composition includes a particulate mixture of solid particles of N-butyloxycarbonyl-3-(4-imidazol-1-ylmethylphenyl)-5-iso-butylthiophene-2-sulfonamide (C21) or a pharmaceutically acceptable salt thereof. The formulation is mixed with carrier particles that have similar physical properties to the solid particles of C21, along with a glidant. This innovative dosage form is encapsulated for effective peroral administration and is particularly useful in treating lung diseases such as idiopathic pulmonary fibrosis, sarcoidosis, and respiratory virus-induced tissue damage. He has 1 patent to his name.
Career Highlights
Stefan Grudén is currently associated with Vicore Pharma AB, where he continues to advance his research and development efforts. His work has been instrumental in creating effective pharmaceutical solutions that address critical health issues.
Collaborations
Stefan collaborates with talented professionals in his field, including Ola Camber and Arnout Everaert. Their combined expertise contributes to the innovative projects at Vicore Pharma AB.
Conclusion
Stefan Grudén's contributions to pharmaceutical innovations highlight his commitment to improving healthcare solutions. His patent for a dry powder composition exemplifies his dedication to addressing significant medical challenges.